Company Announcements

Director/PDMR Shareholding

Source: RNS
RNS Number : 6587A
Haleon PLC
26 September 2022
 

HALEON PLC

 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

26 September 2022

Notification and Public Disclosure in accordance with the requirements of The EU Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and Persons Closely Associated with them.

On 23 September 2022, Haleon plc (the "Company") received notification of the following transactions as detailed below.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Deirdre Mahlan

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director - Person Discharging Managerial Responsibilities

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Haleon plc

b)

 

LEI

 

549300PSB3WWEODCUP19

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Haleon plc American Depositary Shares (ADS)



Identification code

US405552100



b)

 

Nature of the transaction

 

 

Purchase of ADSs in the Company to be held in the Deirdre Mahlan Trust.

 

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




$6.05

20,000







d)

 

Aggregated information




- Aggregated volume

20,000



- Price

$6.05 per share



e)

 

Date of the transaction

 

23 September 2022

f)

 

Place of the transaction

 

New York Stock Exchange

 

 

 

Amanda Mellor

Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDCIXDDGDL